WO2003093338A3 - Biodegradable polymer for marking tissue and sealing tracts - Google Patents

Biodegradable polymer for marking tissue and sealing tracts Download PDF

Info

Publication number
WO2003093338A3
WO2003093338A3 PCT/US2003/012652 US0312652W WO03093338A3 WO 2003093338 A3 WO2003093338 A3 WO 2003093338A3 US 0312652 W US0312652 W US 0312652W WO 03093338 A3 WO03093338 A3 WO 03093338A3
Authority
WO
WIPO (PCT)
Prior art keywords
sealant
tissue
biodegradable polymer
tracts
sealing
Prior art date
Application number
PCT/US2003/012652
Other languages
French (fr)
Other versions
WO2003093338B1 (en
WO2003093338A2 (en
Inventor
John S Fisher
Frederick Ahari
Lucjan J J Hronowski
Original Assignee
Biopsy Sciences Llc
John S Fisher
Frederick Ahari
Lucjan J J Hronowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopsy Sciences Llc, John S Fisher, Frederick Ahari, Lucjan J J Hronowski filed Critical Biopsy Sciences Llc
Priority to EP03733880A priority Critical patent/EP1572006A4/en
Priority to CA2483580A priority patent/CA2483580C/en
Priority to AU2003239163A priority patent/AU2003239163A1/en
Publication of WO2003093338A2 publication Critical patent/WO2003093338A2/en
Publication of WO2003093338A3 publication Critical patent/WO2003093338A3/en
Publication of WO2003093338B1 publication Critical patent/WO2003093338B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00898—Material properties expandable upon contact with fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/44—Radioisotopes, radionuclides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Abstract

A tissue marker (14) formed of a biodegradable polymer (10) having drug-delivery capabilities is combined with a sealant (12) that encapsulates the tissue marker and which serves to help anchor the tissue marker against migration. The sealant (12) is delivered to a site in dehydrated form and moisture inherent in tissue at the site expands the sealant. The expanded sealant is formed of a hydrogel and is therefore more compatible to the surrounding tissue than the material of the tissue marker. The sealant and the tissue marker are both bioabsorbed over time.
PCT/US2003/012652 2002-05-03 2003-04-03 Biodegradable polymer for marking tissue and sealing tracts WO2003093338A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03733880A EP1572006A4 (en) 2002-05-03 2003-04-03 Biodegradable polymer for marking tissue and sealing tracts
CA2483580A CA2483580C (en) 2002-05-03 2003-04-03 Biodegradable polymer for marking tissue and sealing tracts
AU2003239163A AU2003239163A1 (en) 2002-05-03 2003-04-03 Biodegradable polymer for marking tissue and sealing tracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/063,620 US7329414B2 (en) 2002-05-03 2002-05-03 Biodegradable polymer for marking tissue and sealing tracts
US10/063,620 2002-05-03

Publications (3)

Publication Number Publication Date
WO2003093338A2 WO2003093338A2 (en) 2003-11-13
WO2003093338A3 true WO2003093338A3 (en) 2005-06-02
WO2003093338B1 WO2003093338B1 (en) 2005-07-21

Family

ID=29399063

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/012652 WO2003093338A2 (en) 2002-05-03 2003-04-03 Biodegradable polymer for marking tissue and sealing tracts

Country Status (5)

Country Link
US (3) US7329414B2 (en)
EP (1) EP1572006A4 (en)
AU (1) AU2003239163A1 (en)
CA (1) CA2483580C (en)
WO (1) WO2003093338A2 (en)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6862470B2 (en) * 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US20090216118A1 (en) 2007-07-26 2009-08-27 Senorx, Inc. Polysaccharide markers
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US7329414B2 (en) * 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
WO2004027285A1 (en) * 2002-09-12 2004-04-01 Luk Lamellen Und Kupplungsbau Beteiligungs Kg Method for reducing juddering vibrations
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US7465279B2 (en) * 2004-03-31 2008-12-16 Ethicon Endo-Surgery, Inc. Marker device and method of deploying a cavity marker using a surgical biopsy device
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US20050281799A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
US20060004400A1 (en) * 2004-06-16 2006-01-05 Mcgurk Erin Method of treating a lung
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7766891B2 (en) * 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
WO2006014567A2 (en) * 2004-07-08 2006-02-09 Pneumrx, Inc. Pleural effusion treatment device, method and material
US8280486B2 (en) * 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
US8442623B2 (en) * 2004-10-13 2013-05-14 Suros Surgical Systems, Inc. Site marker visible under multiple modalities
US8060183B2 (en) * 2004-10-13 2011-11-15 Suros Surgical Systems, Inc. Site marker visible under multiple modalities
US8433391B2 (en) * 2004-10-13 2013-04-30 Suros Surgical Systems, Inc. Site marker
US20060079805A1 (en) * 2004-10-13 2006-04-13 Miller Michael E Site marker visable under multiple modalities
EP1816945B1 (en) 2004-11-23 2019-08-21 PneumRx, Inc. Steerable device for accessing a target site
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US8715708B2 (en) * 2005-08-31 2014-05-06 University Of Maryland Cyclic acetal biomaterials
US20080234532A1 (en) * 2005-10-22 2008-09-25 Invibio Limited Fiducial marker
US7702378B2 (en) * 2005-11-17 2010-04-20 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US11241296B2 (en) * 2005-11-17 2022-02-08 Breast-Med, Inc. Imaging fiducial markers and methods
JP2009529668A (en) * 2006-03-10 2009-08-20 マギル ユニバーシティー Ultrasonic molecular sensor and use thereof
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) * 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US11129690B2 (en) 2006-03-28 2021-09-28 Devicor Medical Products, Inc. Method for making hydrogel markers
US20170066162A9 (en) * 2006-03-28 2017-03-09 Devicor Medical Products, Inc. Method of Enhancing Ultrasound Visibility of Hyperechoic Materials
US8939910B2 (en) * 2006-03-28 2015-01-27 Devicor Medical Products, Inc. Method for enhancing ultrasound visibility of hyperechoic materials
US7975697B2 (en) 2006-05-11 2011-07-12 Conceptus, Inc. Methods and apparatus for occluding reproductive tracts to effect contraception
US10208158B2 (en) 2006-07-10 2019-02-19 Medipacs, Inc. Super elastic epoxy hydrogel
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
FR2908775B1 (en) * 2006-11-17 2012-08-31 Biomatlante HYDROGEL AND ITS BIOMEDICAL APPLICATIONS
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
EP2101670B1 (en) 2006-12-18 2013-07-31 C.R.Bard, Inc. Biopsy marker with in situ-generated imaging properties
US20080306582A1 (en) * 2007-06-05 2008-12-11 Yunbing Wang Implantable medical devices with elastomeric copolymer coatings
US8100129B2 (en) * 2007-08-28 2012-01-24 Conceptus, Inc. Methods and devices for occluding an ovarian pathway
US9814553B1 (en) * 2007-10-10 2017-11-14 Abbott Cardiovascular Systems Inc. Bioabsorbable semi-crystalline polymer for controlling release of drug from a coating
EP2227635A2 (en) 2007-12-03 2010-09-15 Medipacs, Inc. Fluid metering device
EP2240110A4 (en) * 2008-01-29 2015-07-01 Superdimension Ltd Target identification tool for intra body localization
US8079964B2 (en) * 2008-02-25 2011-12-20 Devicor Medical Products, Inc. Method and apparatus for inserting biopsy site marker in marker body
US8068895B2 (en) * 2008-02-25 2011-11-29 Devicor Medical Products, Inc. Biopsy site marker deployment instrument
US10799593B2 (en) 2008-06-09 2020-10-13 Northwestern University Nanodiamond particle complexes
US20100040672A1 (en) * 2008-06-09 2010-02-18 Northwestern University Delivery of therapeutics
US8050742B2 (en) * 2008-07-30 2011-11-01 Devicor Medical Products, Inc. Biopsy device
DE102008037314B3 (en) * 2008-08-01 2010-03-04 Otto-Von-Guericke-Universität Magdeburg Medizinische Fakultät Marking clip for a region of the inner stomach or intestinal wall
US9173669B2 (en) 2008-09-12 2015-11-03 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US20100081926A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081916A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Histological facilitation systems and methods
US20100081915A1 (en) * 2008-09-29 2010-04-01 Searete Llc, Alimited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081924A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081928A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological Facilitation systems and methods
US20100081927A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100121187A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
US8535261B2 (en) * 2008-11-10 2013-09-17 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
US20100119455A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
US20100121177A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
US20100121581A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
US8394638B2 (en) * 2008-11-10 2013-03-12 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
US8591454B2 (en) * 2008-11-10 2013-11-26 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
US20100121176A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
WO2010077244A1 (en) 2008-12-30 2010-07-08 C.R. Bard Inc. Marker delivery device for tissue marker placement
CN104622599B (en) 2009-05-18 2017-04-12 纽姆克斯股份有限公司 Cross-sectional modification during deployment of an elongate lung volume reduction device
US9014787B2 (en) 2009-06-01 2015-04-21 Focal Therapeutics, Inc. Bioabsorbable target for diagnostic or therapeutic procedure
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
US20110028831A1 (en) * 2009-07-30 2011-02-03 Kent James P Permanently visible implantable fiduciary tissue marker
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
JP2013509963A (en) 2009-11-09 2013-03-21 スポットライト テクノロジー パートナーズ エルエルシー Fragmented hydrogel
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US9427186B2 (en) * 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
US10634741B2 (en) * 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
JP2013516236A (en) * 2009-12-30 2013-05-13 エーエムエス リサーチ コーポレイション Elongated graft system and method for treating pelvic disease
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
WO2011110177A1 (en) * 2010-03-09 2011-09-15 Lina Medical Aps Contraceptive device
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
US8360765B2 (en) 2011-01-07 2013-01-29 Covidien Lp Systems and method for forming a coaxial implant
CN104302689A (en) 2012-03-14 2015-01-21 麦德医像公司 Smart polymer materials with excess reactive molecules
US20130289389A1 (en) 2012-04-26 2013-10-31 Focal Therapeutics Surgical implant for marking soft tissue
US9854259B2 (en) * 2012-07-09 2017-12-26 Qualcomm Incorporated Smoothing of difference reference picture
WO2014081940A1 (en) * 2012-11-21 2014-05-30 Trustees Of Boston University Tissue markers and uses thereof
BR112015022129B1 (en) 2013-03-11 2022-04-19 Endomagnetics Ltd Hyposmotic solutions for lymph node detection
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US20140276200A1 (en) * 2013-03-15 2014-09-18 Covidien Lp Microwave energy-delivery device and system
US9301723B2 (en) * 2013-03-15 2016-04-05 Covidien Lp Microwave energy-delivery device and system
US9161814B2 (en) 2013-03-15 2015-10-20 Covidien Lp Microwave energy-delivery device and system
US9119650B2 (en) 2013-03-15 2015-09-01 Covidien Lp Microwave energy-delivery device and system
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
EP3171820B1 (en) 2014-07-25 2022-11-16 Hologic, Inc. Implantable devices and techniques for oncoplastic surgery
US11227427B2 (en) 2014-08-11 2022-01-18 Covidien Lp Treatment procedure planning system and method
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9795455B2 (en) 2014-08-22 2017-10-24 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US10624697B2 (en) 2014-08-26 2020-04-21 Covidien Lp Microwave ablation system
CN113558782A (en) 2015-06-04 2021-10-29 安都磁学有限公司 Marker materials and forms for Magnetic Marker Localization (MML)
JP6914932B2 (en) 2015-11-11 2021-08-04 デビコー・メディカル・プロダクツ・インコーポレイテッドＤｅｖｉｃｏｒ Ｍｅｄｉｃａｌ Ｐｒｏｄｕｃｔｓ， Ｉｎｃ． Marker sending device and how to deploy markers
US10813692B2 (en) 2016-02-29 2020-10-27 Covidien Lp 90-degree interlocking geometry for introducer for facilitating deployment of microwave radiating catheter
KR20190121772A (en) 2017-02-27 2019-10-28 아벤트, 인크. Methods and systems for improving the positioning accuracy of high frequency ablation procedures through reference marking
CN110709110B (en) * 2017-04-05 2023-05-16 赛特博恩医疗有限公司 Implant with altered properties
US20230220627A1 (en) * 2018-02-13 2023-07-13 Multi-Forms Corporation Water & Oil Impermeable Paper Products, Paper Bags and the Process for Manufacturing the Same
US11779397B2 (en) 2019-05-08 2023-10-10 Atricure, Inc. Biological tissue position location and marking
CN113873963A (en) * 2019-05-30 2021-12-31 Devicor医疗产业收购公司 Biopsy site marker for limited migration
US20220039907A1 (en) * 2020-08-07 2022-02-10 The Board Of Regents Of The University Of Oklahoma Inhibiting Post-Biopsy Inflammation and Metastasis
CN112999425B (en) * 2021-03-01 2022-03-25 浙江大学 Double-layer hydrogel tubular tissue engineering scaffold and preparation method thereof
US11083464B1 (en) 2021-03-12 2021-08-10 Med-Genesis, Llc Multistage bioabsorbable plug system and method of insertion
US11154281B1 (en) 2021-04-13 2021-10-26 Med-Genesis, Llc Sealant plug delivery system and method of use
WO2023012223A1 (en) 2021-08-04 2023-02-09 Surgmark Gmbh Tissue marker

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6427081B1 (en) * 1999-02-02 2002-07-30 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6592608B2 (en) * 2001-12-07 2003-07-15 Biopsy Sciences, Llc Bioabsorbable sealant
US6699205B2 (en) * 1998-06-22 2004-03-02 Artemis Medical, Inc. Biopsy localization method and device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053019T3 (en) * 1986-07-30 1994-07-16 Sumitomo Pharma SOLID PREPARATION ADMINISTRATION INSTRUMENT.
US5562099A (en) * 1990-10-05 1996-10-08 Massachusetts Institute Of Technology Polymeric microparticles containing agents for imaging
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
DK0627911T3 (en) 1992-02-28 2000-11-20 Univ Texas Photopolymerizable biodegradable hydrogels as tissue contact materials and controlled release carriers
US5326350A (en) * 1992-05-11 1994-07-05 Li Shu Tung Soft tissue closure systems
US5273051A (en) * 1993-03-16 1993-12-28 Wilk Peter J Method and associated device for obtaining a biopsy of tissues of an internal organ
WO1998012274A1 (en) 1996-09-23 1998-03-26 Chandrashekar Pathak Methods and devices for preparing protein concentrates
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US7790192B2 (en) 1998-08-14 2010-09-07 Accessclosure, Inc. Apparatus and methods for sealing a vascular puncture
WO2001008578A1 (en) * 1999-07-30 2001-02-08 Vivant Medical, Inc. Device and method for safe location and marking of a cavity and sentinel lymph nodes
US6687974B1 (en) * 1999-12-27 2004-02-10 Mitsubishi Denki Kabushiki Kaisha Method for manufacturing an alternator
US6350244B1 (en) 2000-02-21 2002-02-26 Biopsy Sciences, Llc Bioabsorable markers for use in biopsy procedures
US7329414B2 (en) * 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
US8262693B2 (en) 2004-11-05 2012-09-11 Accessclosure, Inc. Apparatus and methods for sealing a vascular puncture

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699205B2 (en) * 1998-06-22 2004-03-02 Artemis Medical, Inc. Biopsy localization method and device
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6427081B1 (en) * 1999-02-02 2002-07-30 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6592608B2 (en) * 2001-12-07 2003-07-15 Biopsy Sciences, Llc Bioabsorbable sealant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1572006A4 *

Also Published As

Publication number Publication date
EP1572006A2 (en) 2005-09-14
EP1572006A4 (en) 2010-12-08
US20080091120A1 (en) 2008-04-17
US20040030262A1 (en) 2004-02-12
AU2003239163A1 (en) 2003-11-17
WO2003093338B1 (en) 2005-07-21
US7972619B2 (en) 2011-07-05
AU2003239163A8 (en) 2003-11-17
WO2003093338A2 (en) 2003-11-13
US20080161848A1 (en) 2008-07-03
US7329414B2 (en) 2008-02-12
CA2483580A1 (en) 2003-11-13
CA2483580C (en) 2010-09-14

Similar Documents

Publication Publication Date Title
WO2003093338A3 (en) Biodegradable polymer for marking tissue and sealing tracts
WO2006060035A3 (en) System and method for attaching soft tissue to bone
WO2003065877A3 (en) Method and apparatus for improved hemostasis and damage control operations
ATE286408T1 (en) SELF-ADHESIVE, HYDRATEABLE MATRIX FOR THERAPEUTIC APPLICATIONS
CA2458012A1 (en) Wall anchor constructs and surface-mounted anchoring systems utilizing the same
WO2004041241A3 (en) Implantable structure for prolonged and controlled release of an active principle
EP1114105A4 (en) Precipitated calcium carbonate product having improved brightness and method of preparing the same
AU2003222660A1 (en) Biodegradable shape memory polymeric sutures
WO2003007839A3 (en) Devices form naturally occurring biologically derived
CA2458008A1 (en) Folded wall anchor and surface-mounted anchoring
WO2003084389A3 (en) Method and barrier for limiting fluid movement through a tissue rent
WO2007076018A3 (en) System and method for attaching soft tissue to bone
CA2329538A1 (en) Directional endoscopic delivery of material
BR0316616A (en) Thermal plaster
AU2003284222A8 (en) Bioabsorbable marker having external anchoring means
ATE484247T1 (en) UNFOLDABLE, PRE-FORMED STRUCTURES FOR UNFOLDING IN REGIONS WITHIN THE BODY
WO2008061216A3 (en) Annular ring implant
EP1752048A3 (en) A chewing gum tablet comprising at least two integral parts
DE60126498D1 (en) Biodegradable surgical implants
AU2001242867A1 (en) Biodegradable thermoplastic material
AU2003272923A1 (en) Surface-treated calcium carbonate and resin composition comprising the same
DE59913940D1 (en) Opaque eye patch
AU2003265447A1 (en) Coating composition including a precipitated calcium carbonate and a ground calcium carbonate
DE60004524D1 (en) BENDABLE FILM, ESPECIALLY PACKAGING FILM, AND METHOD FOR THE PRODUCTION THEREOF
AU1884301A (en) Photograph-holder made of flexible sheet material and punched sheet for the manufacture thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2483580

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003733880

Country of ref document: EP

B Later publication of amended claims

Effective date: 20050517

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2003733880

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)